Synthesis of VIP-Lipopeptide Using a New Linker to Modify Liposomes: Towards the Development of a Drug Delivery System for Active Targeting
-
- Masaka Toru
- School of Pharmaceutical Sciences, Toho University Sakura Medical Center, Toho University
-
- Matsuda Takuya
- School of Pharmaceutical Sciences, Toho University
-
- Li Yingpeng
- School of Pharmaceutical Sciences, Toho University
-
- Koide Yuki
- School of Pharmaceutical Sciences, Toho University
-
- Takami Akira
- School of Pharmaceutical Sciences, Toho University
-
- Yano Kenji
- School of Pharmaceutical Sciences, Toho University
-
- Imai Ryosuke
- School of Pharmaceutical Sciences, Toho University
-
- Ichihara Risa
- School of Pharmaceutical Sciences, Toho University
-
- Yagi Nobuhiro
- School of Pharmaceutical Sciences, Toho University
-
- Suzuki Hideharu
- School of Pharmaceutical Sciences, Toho University
-
- Hikawa Hidemasa
- School of Pharmaceutical Sciences, Toho University
-
- Terada Katsuhide
- School of Pharmaceutical Sciences, Toho University
-
- Yokoyama Yuusaku
- School of Pharmaceutical Sciences, Toho University
Search this article
Abstract
A new component for the solid phase peptide synthesis of lipopeptide, 2-[(4R,5R)-5-({[(9H-fluoren-9-yl)methoxy]carbonylaminomethyl}-2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]acetic acid (2), was designed and synthesized from (−)-2,3-O-isopropylidene-D-threitol (3) in 4 steps. The key step was the selective alkylation of 3 with benzyl bromoacetate in the presence of Cs2CO3. Vasoactive intestinal peptide (VIP)-lipopeptide (1) incorporating this linker was synthesized by solid phase peptide synthesis.
Journal
-
- Chemical and Pharmaceutical Bulletin
-
Chemical and Pharmaceutical Bulletin 61 (11), 1184-1187, 2013
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204177923968
-
- NII Article ID
- 130003360912
-
- NII Book ID
- AA00602100
-
- COI
- 1:STN:280:DC%2BC3sbisFyitw%3D%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL BIB ID
- 024957254
-
- PubMed
- 23979293
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed